Fortress Biotech (FBIO) Misses Q3 EPS by 72c

Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.94), $0.72 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.75 million versus the consensus estimate of $14.28 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears